Literature DB >> 11798164

The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues.

Giovanna Maria Pierantoni1, Alessandro Bulfone, Francesca Pentimalli, Monica Fedele, Rodolfo Iuliano, Massimo Santoro, Lorenzo Chiariotti, Andrea Ballabio, Alfredo Fusco.   

Abstract

The HIPK2 protein is a member of a recently identified family of nuclear protein kinases that interact with homeodomain transcription factors and that are well conserved in various organisms. HIPK2 acts as a transcriptional co-repressor of homeoproteins and it is a component of a co-repressor complex containing Groucho and a histone deacetylase. We have recently demonstrated that the HIPK2 protein interacts with HMGA1 proteins in vitro and in vivo and that HIPK2 exerts a potent inhibitory effect on the cell growth of different normal cell lines. Here we demonstrate that the HIPK2 gene is expressed during the latest phases of embryogenesis, and preferentially in retina, in muscle and in neural tissues. Conversely, HIPK2 is ubiquitously expressed in murine and human adult tissues. We have also found that HIPK2 expression is reduced in breast and thyroid carcinomas, suggesting a role of this gene in the process of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11798164     DOI: 10.1006/bbrc.2001.6310

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Phosphoregulators: protein kinases and protein phosphatases of mouse.

Authors:  Alistair R R Forrest; Timothy Ravasi; Darrin Taylor; Thomas Huber; David A Hume; Sean Grimmond
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

2.  Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.

Authors:  Hiroki Hikasa; Sergei Y Sokol
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 3.  Wnt signaling through T-cell factor phosphorylation.

Authors:  Sergei Y Sokol
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

4.  Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.

Authors:  Barbara Cecchinelli; Luca Lavra; Cinzia Rinaldo; Stefano Iacovelli; Aymone Gurtner; Alessandra Gasbarri; Alessandra Ulivieri; Fabrizio Del Prete; Maria Trovato; Giulia Piaggio; Armando Bartolazzi; Silvia Soddu; Salvatore Sciacchitano
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  Molecular analysis of oncogenicity of the transcription factor, BRN3A, in cervical cancer cells.

Authors:  Biswa Pratim Das Purkayastha; Jagat Kumar Roy
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-18       Impact factor: 4.553

Review 6.  Posttranslational modifications regulate HIPK2, a driver of proliferative diseases.

Authors:  Vera V Saul; M Lienhard Schmitz
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

7.  Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.

Authors:  Kyoichi Isono; Kazumi Nemoto; Yuanyuan Li; Yuki Takada; Rie Suzuki; Motoya Katsuki; Akira Nakagawara; Haruhiko Koseki
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression.

Authors:  Martha F Kramer; W James Cook; Frederick P Roth; Jia Zhu; Holly Holman; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.

Authors:  Lavinia Nardinocchi; Rosa Puca; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

10.  HIPK2 modulates p53 activity towards pro-apoptotic transcription.

Authors:  Rosa Puca; Lavinia Nardinocchi; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  Mol Cancer       Date:  2009-10-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.